New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of life in patients with eosinophilic chronic obstructive pulmonary disease (COPD ...
HealthDay News — Implementation of a computerized multidisciplinary order set in the electronic health record improves the quality of physician pharmacologic prescribing for patients hospitalized for ...
Please provide your email address to receive an email when new articles are posted on . This study population represents patients with COPD and Th2 inflammation that clinicians treat daily. Included ...
Patients with acute COPD exacerbations are seen frequently in the emergency department (ED). Acute exacerbations are associated with significant morbidity, mortality and health care expenditures.
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has highlighted recent advances in understanding and managing COPD, particularly in relation to its ...
—Theses investigators found an increased risk for both individual and composite cardiovascular events following exacerbations of COPD, with sustained risk after 1 year regardless of severity. Reviewed ...
Efficacy and safety of combination therapy versus monotherapy in advanced non-small cell lung cancer: A meta-analysis of overall survival and progression-free survival. Dynamic combined monitoring of ...
Please provide your email address to receive an email when new articles are posted on . An AI had high performance in predicting COPD exacerbations using patients’ body temperature data. Thirty-seven ...
GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate that as of 2019, about 400 million people around ...
VIENNA — Documenting airway thickness in patients with chronic obstructive pulmonary disease (COPD) can help physicians target eosinophilic airway inflammation with biologics, researchers suggested at ...
Almost 16 million adults have COPD in the United States and about 3 in 4 people with this condition have at least one flare (exacerbation) a year, cites a review. But you don’t have to sit and wait ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results